Please use this identifier to cite or link to this item:
Title: Is aspirin associated with diabetic retinopathy? The Singapore Epidemiology of Eye Disease (SEED) study
Authors: Shi Y. 
Tham Y.-C. 
Cheung N. 
Chua J. 
Tan G. 
Mitchell P.
Wang J.J. 
Cheung Y.B. 
Cheng C.-Y. 
Wong T.Y. 
Keywords: acetylsalicylic acid
acetylsalicylic acid
cross-sectional study
diabetic retinopathy
drug use
eye photography
macular edema
major clinical study
middle aged
chemically induced
diabetic retinopathy
regression analysis
Diabetic Retinopathy
Middle Aged
Regression Analysis
Issue Date: 2017
Publisher: Public Library of Science
Citation: Shi Y., Tham Y.-C., Cheung N., Chua J., Tan G., Mitchell P., Wang J.J., Cheung Y.B., Cheng C.-Y., Wong T.Y. (2017). Is aspirin associated with diabetic retinopathy? The Singapore Epidemiology of Eye Disease (SEED) study. PLoS ONE 12 (4) : e0175966. ScholarBank@NUS Repository.
Abstract: Background/Aims To determine the association between aspirin use and diabetic retinopathy (DR) among persons with diabetes, in a population-based, cross-sectional study. Methods Subjects with diabetes aged >40 years from the Singapore Epidemiology of Eye Diseases Study were enrolled in this study. Retinal photographs were graded for DR according to the modified Airlie House classification system. Vision threatening diabetic retinopathy (VTDR) was defined as the presence of severe non-proliferative DR, or proliferative DR, or clinically significant macular oedema. The association between aspirin use and the presence of DR or VTDR was assessed using multivariable logistic regression models including age, gender, ethnicity, socioeconomic status, HbA1c, systolic blood pressure, anti-hypertension medicine, total cholesterol, anti-cholesterol medicine, BMI, current smoking status, diabetes duration, history of cardiovascular disease (CVD) and chronic kidney disease (CKD.). Results A total of 2,061 participants with diabetes and complete record of relevant systemic and DR data were included. Of these, 711 (34.5%) had any stage of DR, and among these 177 (8.6%) had VTDR. After adjusting for co-variables listed, the association between aspirin use and VTDR was significant (OR = 1.69, P = 0.019), while the association between aspirin use and any DR was borderline (OR = 1.31, P = 0.063). Aspirin use was not associated with either DR or VTDR after additional adjustment of CVD and CKD. Further stratification by history of CVD or CKD showed no association between aspirin use and DR/VTDR in either subgroup.Conclusion Aspirin use was not significantly associated with DR but might be an indicator of diabetic complications (CVD, CKD) that were co-present with more severe DR type. Future longitudinal studies are warranted to confirm our findings. © 2017 Shi et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Source Title: PLoS ONE
ISSN: 19326203
DOI: 10.1371/journal.pone.0175966
Appears in Collections:Elements
Staff Publications

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_1371_journal_pone_0175966.pdf616.29 kBAdobe PDF



Google ScholarTM



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.